These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33463720)

  • 21. New subtype of PCH1C caused by novel EXOSC8 variants in a 16-year-old Spanish patient.
    Rodríguez-García ME; Cotrina-Vinagre FJ; Bellusci M; Merino-López A; Chumilla-Calzada S; García-Silva MT; Martínez-Azorín F
    Neuromuscul Disord; 2021 Aug; 31(8):773-782. PubMed ID: 34210538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature.
    Ivanov I; Atkinson D; Litvinenko I; Angelova L; Andonova S; Mumdjiev H; Pacheva I; Panova M; Yordanova R; Belovejdov V; Petrova A; Bosheva M; Shmilev T; Savov A; Jordanova A
    Eur J Paediatr Neurol; 2018 Jul; 22(4):674-681. PubMed ID: 29656927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecularly confirmed pontocerebellar hypoplasia in a large family from Slovakia with four severely affected children.
    Radvanska E; Pos Z; Zatkova A; Hyblova M; Bauer F; Szemes T; Kadasi L; Radvanszky J
    Bratisl Lek Listy; 2022; 123(8):568-572. PubMed ID: 35852507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations.
    Eggens VR; Barth PG; Niermeijer JM; Berg JN; Darin N; Dixit A; Fluss J; Foulds N; Fowler D; Hortobágyi T; Jacques T; King MD; Makrythanasis P; Máté A; Nicoll JA; O'Rourke D; Price S; Williams AN; Wilson L; Suri M; Sztriha L; Dijns-de Wissel MB; van Meegen MT; van Ruissen F; Aronica E; Troost D; Majoie CB; Marquering HA; Poll-Thé BT; Baas F
    Orphanet J Rare Dis; 2014 Feb; 9():23. PubMed ID: 24524299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel EXOSC3 pathogenic variant results in a mild course of neurologic disease with cerebellum involvement.
    Le Duc D; Horn S; Jamra RA; Schaper J; Wieczorek D; Redler S
    Eur J Med Genet; 2020 Feb; 63(2):103649. PubMed ID: 30986545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pontocerebellar hypoplasia type 11: Does the genetic defect determine timing of cerebellar pathology?
    Laugwitz L; Buchert R; Groeschel S; Riess A; Grimmel M; Beck-Wödl S; Sturm M; Gohla G; Döbler-Neumann M; Krägeloh-Mann I; Haack TB
    Eur J Med Genet; 2020 Jul; 63(7):103938. PubMed ID: 32360255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EXOSC3 mutations in isolated cerebellar hypoplasia and spinal anterior horn involvement.
    Biancheri R; Cassandrini D; Pinto F; Trovato R; Di Rocco M; Mirabelli-Badenier M; Pedemonte M; Panicucci C; Trucks H; Sander T; Zara F; Rossi A; Striano P; Minetti C; Santorelli FM
    J Neurol; 2013 Jul; 260(7):1866-70. PubMed ID: 23564332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcomeric disorganization and nemaline bodies in muscle biopsies of patients with EXOSC3-related type 1 pontocerebellar hypoplasia.
    Pinto MM; Monges S; Malfatti E; Lubieniecki F; Lornage X; Alias L; Labasse C; Madelaine A; Fardeau M; Laporte J; Tizzano EF; Romero NB
    Muscle Nerve; 2019 Jan; 59(1):137-141. PubMed ID: 30025162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome sequencing in a family with intellectual disability, early onset spasticity, and cerebellar atrophy detects a novel mutation in EXOSC3.
    Zanni G; Scotton C; Passarelli C; Fang M; Barresi S; Dallapiccola B; Wu B; Gualandi F; Ferlini A; Bertini E; Wei W
    Neurogenetics; 2013 Nov; 14(3-4):247-50. PubMed ID: 23975261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RNA Exosome and Human Disease.
    Fasken MB; Morton DJ; Kuiper EG; Jones SK; Leung SW; Corbett AH
    Methods Mol Biol; 2020; 2062():3-33. PubMed ID: 31768969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2 new cases of pontocerebellar hypoplasia type 10 identified by whole exome sequencing in a Turkish family.
    Wafik M; Taylor J; Lester T; Gibbons RJ; Shears DJ
    Eur J Med Genet; 2018 May; 61(5):273-279. PubMed ID: 29307788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homozygous variants in AMPD2 and COL11A1 lead to a complex phenotype of pontocerebellar hypoplasia type 9 and Stickler syndrome type 2.
    Abreu NJ; Koboldt DC; Gastier-Foster JM; Dave-Wala A; Flanigan KM; Waldrop MA
    Am J Med Genet A; 2020 Mar; 182(3):557-560. PubMed ID: 31833174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations.
    Rudnik-Schöneborn S; Senderek J; Jen JC; Houge G; Seeman P; Puchmajerová A; Graul-Neumann L; Seidel U; Korinthenberg R; Kirschner J; Seeger J; Ryan MM; Muntoni F; Steinlin M; Sztriha L; Colomer J; Hübner C; Brockmann K; Van Maldergem L; Schiff M; Holzinger A; Barth P; Reardon W; Yourshaw M; Nelson SF; Eggermann T; Zerres K
    Neurology; 2013 Jan; 80(5):438-46. PubMed ID: 23284067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.
    Boczonadi V; Müller JS; Pyle A; Munkley J; Dor T; Quartararo J; Ferrero I; Karcagi V; Giunta M; Polvikoski T; Birchall D; Princzinger A; Cinnamon Y; Lützkendorf S; Piko H; Reza M; Florez L; Santibanez-Koref M; Griffin H; Schuelke M; Elpeleg O; Kalaydjieva L; Lochmüller H; Elliott DJ; Chinnery PF; Edvardson S; Horvath R
    Nat Commun; 2014 Jul; 5():4287. PubMed ID: 24989451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma.
    Schwabova J; Brozkova DS; Petrak B; Mojzisova M; Pavlickova K; Haberlova J; Mrazkova L; Hedvicakova P; Hornofova L; Kaluzova M; Fencl F; Krutova M; Zamecnik J; Seeman P
    J Neurogenet; 2013 Dec; 27(4):163-9. PubMed ID: 23883322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel compound heterozygous variant of TOE1 results in a mild type of pontocerebellar hypoplasia type 7: an expansion of the clinical phenotype.
    Chen H; Li N; Xu Y; Li G; Song C; Yao RE; Yu T; Wang J; Yang L
    Neurogenetics; 2022 Jan; 23(1):11-17. PubMed ID: 34716526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pontocerebellar Hypoplasia Type 1D: A Case Report and Comprehensive Literature Review.
    Dabaj I; Hassani A; Burglen L; Qebibo L; Guerrot AM; Marret S; Tebani A; Bekri S
    J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35893425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration.
    Wan J; Yourshaw M; Mamsa H; Rudnik-Schöneborn S; Menezes MP; Hong JE; Leong DW; Senderek J; Salman MS; Chitayat D; Seeman P; von Moers A; Graul-Neumann L; Kornberg AJ; Castro-Gago M; Sobrido MJ; Sanefuji M; Shieh PB; Salamon N; Kim RC; Vinters HV; Chen Z; Zerres K; Ryan MM; Nelson SF; Jen JC
    Nat Genet; 2012 Apr; 44(6):704-8. PubMed ID: 22544365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Frameshift
    Ahn JH; Oh SH; Park JK; Kim KH; Lee JE; Chung WY; Lee KS; Seo GH; Lee BL
    Ann Clin Lab Sci; 2022 May; 52(3):488-493. PubMed ID: 35777792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WDR73 missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in a consanguineous family.
    Jiang C; Gai N; Zou Y; Zheng Y; Ma R; Wei X; Liang D; Wu L
    Clin Chim Acta; 2017 Jan; 464():24-29. PubMed ID: 27983999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.